Molecular Analysis Improves FH Prognosis & Risk Stratification
Physician's Weekly
JUNE 24, 2025
Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy. Familial hypercholesterolemia is one subset of hypercholesterolemia. Through testing that screened for 11 genetic markers, 67.9% of those with a score of 6-7 and 85.7%
Let's personalize your content